Editorial: Innovative Biologics and Drugs to Target Renal Inflammation

Saved in:

Bibliographic Details
Main Authors:	Matthew D. Griffin (Author), Sundararaman Swaminathan (Author)
Format:	Book
Published:	Frontiers Media S.A., 2020-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

MARC


LEADER	00000 am a22000003u 4500
001	doaj_e997c788e23c4a6eb6801f5a0c60c818
042			\|a dc
100	1	0	\|a Matthew D. Griffin \|e author
700	1	0	\|a Sundararaman Swaminathan \|e author
245	0	0	\|a Editorial: Innovative Biologics and Drugs to Target Renal Inflammation
260			\|b Frontiers Media S.A., \|c 2020-02-01T00:00:00Z.
500			\|a 1663-9812
500			\|a 10.3389/fphar.2020.00038
546			\|a EN
690			\|a Chronic Kidney Disease
690			\|a Acute Kidney Injury
690			\|a Inflammation
690			\|a Therapeutic Targets
690			\|a Diabetic Nephropathy
690			\|a Sepsis
690			\|a Therapeutics. Pharmacology
690			\|a RM1-950
655	7		\|a article \|2 local
786	0		\|n Frontiers in Pharmacology, Vol 11 (2020)
787	0		\|n https://www.frontiersin.org/article/10.3389/fphar.2020.00038/full
787	0		\|n https://doaj.org/toc/1663-9812
856	4	1	\|u https://doaj.org/article/e997c788e23c4a6eb6801f5a0c60c818 \|z Connect to this object online.